Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada
Background: Chronic HBV within the Canadian Arctic is considered endemic (>2% prevalence). To control endemic rates in Nunavut, a vaccination program was initiated approximately 20 years ago, targeted at newborns and grade school students, as an interim catch-up program, such that all individuals...
Main Author: | Huynh, Chris |
---|---|
Other Authors: | Osiowy, Carla (Medical Microbiology) |
Published: |
2015
|
Subjects: | |
Online Access: | http://hdl.handle.net/1993/30183 |
Similar Items
-
Investigation on the Efficacy of Intradermal Hepatitis B Vaccination
by: Elif DOYUK, et al.
Published: (2000-12-01) -
Clinical cancer chemoprevention: From the hepatitis B virus (HBV) vaccine to the human papillomavirus (HPV) vaccine
by: Horng-Jyh Tsai
Published: (2015-04-01) -
THE COURSE OF CHRONIC HEPATITIS B IN INFANTS BORN TO MOTHERS WITH HBV-INFECTION
by: L. G. Goriacheva, et al.
Published: (2015-09-01) -
No evidence for occult HBV infection in hepatitis B vaccine non-responders
by: Mohammad Reza Aghasadeghi, et al.
Published: (2014-10-01) -
Coverage with Timely Administered Vaccination against Hepatitis B Virus and Its Influence on the Prevalence of HBV Infection in the Regions of Different Endemicity
by: Karen K. Kyuregyan, et al.
Published: (2021-01-01)